1. Wang, Ning, Guo, Shaochen, Liu, Haiting, Chen, Xiaoyou, Lu, Yu. 2022. Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity. In Xenobiotica; the fate of foreign compounds in biological systems, 52, 520-526. doi:10.1080/00498254.2022.2092783. https://pubmed.ncbi.nlm.nih.gov/35723590/
2. Flannigan, Kyle L, Nieves, Kristoff M, Szczepanski, Holly E, Mani, Sridhar, Hirota, Simon A. 2022. The Pregnane X Receptor and Indole-3-Propionic Acid Shape the Intestinal Mesenchyme to Restrain Inflammation and Fibrosis. In Cellular and molecular gastroenterology and hepatology, 15, 765-795. doi:10.1016/j.jcmgh.2022.10.014. https://pubmed.ncbi.nlm.nih.gov/36309199/
3. Medeiros, Rúbia Marília de, Menti, Carolina Fialho, Benelli, Jéssica Louise, Almeida, Sabrina Esteves de Matos, Fiegenbaum, Marilu. . Association of NR1I2 gene polymorphisms and time of progression to AIDS. In Memorias do Instituto Oswaldo Cruz, 112, 269-274. doi:10.1590/0074-02760160382. https://pubmed.ncbi.nlm.nih.gov/28327790/
4. Zhang, Jinhang, Huang, Ya, Li, Hong, He, Jinhan, Li, Yanping. 2024. B3galt5 functions as a PXR target gene and regulates obesity and insulin resistance by maintaining intestinal integrity. In Nature communications, 15, 5919. doi:10.1038/s41467-024-50198-z. https://pubmed.ncbi.nlm.nih.gov/39004626/
5. Yang, Miaomiao, Qiu, Yunliang, Jin, Yanyu, Yi, Honggang, Tang, Shaowen. . NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis. In Pharmacology research & perspectives, 8, e00696. doi:10.1002/prp2.696. https://pubmed.ncbi.nlm.nih.gov/33300686/
6. Sun, Man-Yi, Lin, Jing-Na. 2016. Relationship between NR1I2 polymorphisms and inflammatory bowel disease risk: A systematic review and meta-analysis. In Clinics and research in hepatology and gastroenterology, 41, 230-239. doi:10.1016/j.clinre.2016.10.006. https://pubmed.ncbi.nlm.nih.gov/27894906/
7. Nilles, Julie, Weiss, Johanna, Masin, Martin, Ruez, Stephanie, Theile, Dirk. 2023. The differences in drug disposition gene induction by rifampicin and rifabutin are unlikely due to different effects on important pregnane X receptor (NR1I2) splice variants. In Naunyn-Schmiedeberg's archives of pharmacology, 397, 2485-2496. doi:10.1007/s00210-023-02768-z. https://pubmed.ncbi.nlm.nih.gov/37851058/
8. Ye, Ji, Huang, Fan, Zeng, Huawu, Zhao, Jing, Zhang, Weidong. 2022. Multi-omics and network pharmacology study reveals the effects of Dengzhan Shengmai capsule against neuroinflammatory injury and thrombosis induced by ischemic stroke. In Journal of ethnopharmacology, 305, 116092. doi:10.1016/j.jep.2022.116092. https://pubmed.ncbi.nlm.nih.gov/36587875/
9. Lima, Luciana O, Almeida, Silvana, Hutz, Mara H, Fiegenbaum, Marilu. 2012. PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms and lipid and lipoprotein levels in a Southern Brazilian population. In Molecular biology reports, 40, 1241-7. doi:10.1007/s11033-012-2166-y. https://pubmed.ncbi.nlm.nih.gov/23079705/